Innovation in Hybrid Imaging – First Time on Stage: SurgicEye’s SPECT⁄Ultrasound System
SurgicEye will present its newly released declipseSPECT Ultrasound System in combination with ultrasound imaging at the German Nuclear Medicine Meeting in Hannover, March 26-29, 2014. The system will be on display and available for hands-on sessions at the booth D8 in the industrial exhibition at the Congress Center in Hannover.more...
SurgicEye will present its 3-D imaging and navigation device declipse®SPECT at the Society of Surgical Oncology (SSO 2014) in Phoenix, AZ
SurgicEye will present its 3-D imaging and navigation device declipse®SPECT at the Society of Surgical Oncology together with their US partner Dilon Diagnostics. SurgicEye has wordwide the first 3-D handheld soft tissue imaging solution that is capable of image guided tumor resection.more...
1st in Asia, Intra Operative 3D Radioguided Surgery System at HCG
Bangalore / Munich, August, 29th, 2013 - HealthCare Global Enterprises Ltd, The Specialist in Cancer Care, today organized a press conference on treating cancer patients for the 1st time in Asia, with Intra Operative 3D Radioguided Surgery System (SurgicEye).more...
declipse®SPECT auf der 33. Jahrestagung der Deutschen Gesellschaft für Senologie, ICM München
Treffen Sie uns zu einem Diskussionsforum mit dem Thema: „3D geführte Wächterlymphknotenbiopsie“ unter Leitung von Dr. Stefan Paepke und Dr. Andreas Schnelzer von der Frauenklinik, Klinikum rechts der Isar der TU München, Donnerstag, den 27.6.2013, von 13.00 - 14.00 Uhr Stand Nr. 205
Affordable Hybrid Imaging and 3D Radio-Guided Surgery at the SNMMI - Annual Meeting 2013 (June 8 - 12, 2013, Vancouver, Canada)
Please visit us during the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) June 8 - 12, 2013 in Vancouver, BC, Canada at booth No. 846 with our US partner Dilon Diagnostics and get hands on the innovation in intraoperative 3D imaging and navigation. Get an appointment scheduled with the declipseSPECT inventor and CTO Dr. Thomas Wendler and our CEO Dr. Joerg Traub!